Sir Frederick Treves first showed Joseph Merrick, the famous Elephant Man, to the Pathological Society of London in 1884. A diagnosis of neurofibromatosis was suggested in 1909 and was widely accepted. There is no evidence, however, of cafe au lait spots or histological proof of neurofibromas. It is also clear that Joseph Merrick's manifestations were much more bizarre than those commonly seen in neurofibromatosis. Evidence indicates that Merrick suffered from the Proteus syndrome and had the following features compatible with this diagnosis: macrocephaly; hyperostosis of the skull; hypertrophy of long bones; and thickened skin and subcutaneous tissues, particularly ofthe hands and feet, including plantar hyperplasia, lipomas, and other unspecified subcutaneous masses.
Introduction
In the British Medical Journal of 6 December 1884 Sir Frederick Treves first reported on "a man who showed an extraordinary appearance owing to a series of deformities."' The subject of these deformities was later described in detail in Transactions of the Pathological Society ofLondon in 1885 as "a man who earned a living by exhibiting himselfas the Elephant Man. "2 At that time no definite diagnosis was reached. In 1909 Parkes Weber first suggested neurofibromatosis as the cause of the Elephant Man's disorder,3 and this was subsequently widely accepted.
We indicate here the lack ofevidence for neurofibromatosis in this patient, compare his condition with that ofa patient with the Proteus syndrome, and explain the reasons why we believe that the Elephant Man meets the criteria for the Proteus syndrome.
Case reports CASE 
1
Joseph Carey Merrick was born in 1862 in Leicester, the obstetric history apparently having been normal. At birth he showed no obvious congenital deformities. The family history was negative for neurofibromatosis: both parents and two subsequent siblings showed no evidence of the disease. Deformities developed during early childhood, being noted initially at about 18 months ofage, and progressed throughout his life. When he was 20 a large portion ofhis facial deformity was successfully removed. When he was 22 his casewas fully described by Treves,2 and during the sixyears ofmedical follow up his deformities increased in extent until he died, apparently ofsuffocation, at the age of28 in 1890. 4 Examination showed a man of "a little below average height" with a head circumferenceof36 inches (91 cm). Hewas ofnormal intelligence. Over much ofhis body the skin was papillomatous and verrucous, and in some areas it was loose and flabby; subcutaneous thickening was evident. The skull was covered with exostoses, and there was localised hypertrophy that was most pronounced in the skull and right arm and overthe feet. The By 5 months of age he was having occasional seizures and there was global developmental retardation. Thickened, wrinkled skin was becoming apparent over the toes and fingers. Computed tomography at 10 months of age showed clear hemimegalencephaly with ventricular dilatation. By the age of 22 months head size had increased to 53 5 cm and soft tissue masses diagnosed by palpation as lipomas were noted on the chest and abdomen. Kyphoscoliosis was becoming apparent.
At 51/2 years ofage there was profound developmental retardation and gross asymmetry of the whole body. The discrepancy in the length of the legs was more pronounced. Asymmetric chest and abdomen were associated with kyphoscoliosis. Large lipomas were present on the left abdomen and over the right breast. Overgrown, redundant tissue was observed as a moccasin lesion of the left foot (fig 2) , producing gross deformity. The right foot had minor discrepancies in the lengths of the toes and medial overlapping of the second -_ toe. The right hand was enlarged and grossly deformed (fig 2) . Linear verrucous epidermal naevi were evident on the left neck and left knee and multiple naevus flammeus-like haemangiomas were present on the left leg, left buttock, and left side ofthe back and abdomen. Important findings in the head and neck region included macrocephaly, severe craniofacial asymmetry (with the left eye larger than the right), redundant skin around the nose, and a pointed chin (fig 3) . Bony hyperostoses were also present, one in the midline just above the nasal bridge and one in the region ofeach ear.
Discussion
The In one study only 6-9Y% were baseline anti-iBs positive and would therefore have been c6nsidered already immune.' Subjects who are anti-HBs positve are not infectious "carriers" having cleared the HB virus and-do not have liver dises. The vaccine is safe to give to thoex already HBV-marker positive but having baseline anti-HBs does not appear to .confer any specific advantage to the overall levels of anti-H&s achieved after the three dose course,, It is more impo to test for anti-Bs af* the three dose course (usually one-to duree months after) siice 5-10% will be shown to be poor (<50mIU/ml)wrnon-respondersrespectively'2adthesearenotnessarily protected from-HBV infection. $ince the anti-HBs levels after vaccnation fallxpo tally, these should be checked after one to two years to detect when they fill below currently accepted limits, namely, 10-50 mIU/ml. Of thoseoriginal whoreceivedafourthdose, anti-Ms levels rose by more than a dhoutndfo1d i ing ta the n may be longer than hitherto realised ' 
